Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Tech Stock to Buy and 1 to Avoid


Tech stocks have generally done well this year, staging a solid recovery from a tough 2022. But not all tech stocks are created equal. AT (NYSE: T) looks like a bargain, while Apple (NASDAQ: AAPL) looks severely overpriced.

There are two core reasons to invest in AT stock: The valuation and the dividend. The stock price reflects an extreme amount of pessimism that looks overdone, and the dividend, while unlikely to grow quickly, has a sky-high yield.

AT expects to generate AT least $16 billion of free cash flow this year despite a slower pace of wireless subscriber additions. With a market capitalization of $114 billion, the stock trades for roughly 7 times free cash flow. That looks like a bargain.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

€0.051
5.150%
A very strong showing by Allergy Therapeutics PLC today, with an increase of €0.003 (5.150%) compared to yesterday's price.

Like: 0
T
Share

Comments